Yingying Xu

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Cancer biology & medicine

Journal of breast cancer

Diabetes, metabolic syndrome and obesity : targets and therapy

Journal of translational internal medicine

The First Hospital of China Medical University

China Medical University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The First Hospital of China Medical University

China

Professor/ Chief physician :: Breast Surgery

MD Anderson Cancer Center

United States

Visiting scholar

The First Hospital of China Medical University

China

Associate Professor/ Associate chief physician :: Breast Surgery

The First Hospital of China Medical University

China

Lecturer/Attending doctor :: Breast Surgery

Education History

China Medical University

China

BSC :: Clinical Medicine

Publications

Yusong Wang, Mozhi Wang, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lyu, Mingke Cui, Qiang Zhang, Yingying Xu
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity. Cancer biology & medicine 20 (3) (2023)
Yusong Wang, Mozhi Wang, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lyu, Mingke Cui, Qiang Zhang, Yingying Xu
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity. Cancer biology & medicine 20 (3) (2023)
Hengjun Zhang, Mozhi Wang, Yingying Xu
Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation. Cancer biology & medicine (2023)
Litong Yao, Xiaoyan Liu, Mozhi Wang, Jinha Yu, Shouping Xu, Pengfei Qiu, Zhidong Lv, Xinwen Zhang, Yingying Xu
Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study. Journal of breast cancer (2023)
Xiuyun Chen, Mozhi Wang, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lyu, Xinwen Zhang, Yingying Xu
Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors. Journal of translational internal medicine 11 (3) (2022)
Xiangyu Sun, Xiaoyan Liu, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lv, Xinwen Zhang, Yingying Xu
Targeting PGC1α to wrestle cancer: a compelling therapeutic opportunity. Journal of cancer research and clinical oncology 148 (4) (2022)
Litong Yao, Zhiyuan Pang, Mozhi Wang, Mengshen Wang, Xiangyu Sun, Mingke Cui, Yanfu Zheng, Xinyan Li, Haoran Dong, Qiang Zhang, Yingying Xu
The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study. Cancer biology & medicine (2021)
Litong Yao, Xinyu Wang, Yifan Zhong, Yan Wang, Jingyang Wu, Jin Geng, Yun Zhou, Jun Chen, Peng Guan, Yingying Xu, Lei Chen, Lei Liu, Yuedong Hu
The Triglyceride-Glucose Index is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes: A Hospital-Based, Nested, Case-Control Study. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)
Litong Yao, Yifan Zhong, Lingzi He, Yan Wang, Jingyang Wu, Jin Geng, Yun Zhou, Jiahua Zhang, Jun Chen, Zhongyan Shan, Weiping Teng, Yingying Xu, Lei Chen, Lei Liu
Serum CA125 Level Is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Xinyan Li, Litong Yao, Mozhi Wang, Mengshen Wang, Xiang Li, Xueting Yu, Jingyi Guo, Haoran Dong, Xiangyu Sun, Yingying Xu
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer. Journal of breast cancer 23 (4) (2020)
Xinyan Li, Mozhi Wang, Mengshen Wang, Xueting Yu, Jingyi Guo, Tie Sun, Litong Yao, Qiang Zhang, Yingying Xu
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy. Journal of breast cancer 22 (4) (2019)
Mozhi Wang, Mengshen Wang, Zhen-Ning Wang, Xueting Yu, Yongxi Song, Chong Wang, Yujie Xu, Fengheng Wei, Yi Zhao, Yingying Xu
Long non-coding RNA-CTD-2108O9.1 represses breast cancer metastasis by influencing leukemia inhibitory factor receptor. Cancer science 109 (6) (2018)

Yingying Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yingying Xu